Title:
ＲＥＩＣ／Ｄｋｋ−３遺伝子およびチェックポイント阻害剤を用いた併用療法
Document Type and Number:
Japanese Patent JP6803619
Kind Code:
B2
Abstract:
An object of the present invention is to provide a method of treating cancer using a checkpoint inhibitor in combination with REIC/Dkk-3 gene. The present invention is a combination pharmaceutical kit for treating cancer comprising REIC/Dkk-3 in combination with a check point inhibitor and a method for treating cancer by administering REIC/Dkk-3 gene and a check point inhibitor to a cancer patient.
More Like This:
| JPH11506320 | INDUSTRIAL APPLICABILITY The abundant extracellular products and methods for producing and using them. |
| JP2001206896 | 2-AMINOPURINE DERIVATIVE |
| WO/2002/014485 | KALLIKREIN GENE |
Inventors:
Kumon Hiromi
Lowenthal Richard
Lowenthal Richard
Application Number:
JP2018535069A
Publication Date:
December 23, 2020
Filing Date:
January 06, 2017
Export Citation:
Assignee:
Momotaro Gen Co., Ltd.
International Classes:
A61K48/00; A61K31/7088; A61K35/761; A61K39/395; A61P35/00
Domestic Patent References:
| JP5447861B2 | ||||
| JP4838236B2 |
Foreign References:
| WO2015069770A1 | ||||
| WO2015092382A1 |
Attorney, Agent or Firm:
Hiraki International Patent Office